GLP-1 weight loss drugs linked to heightened GI risks, says new study

FHS
October 5, 2023
11:04 pm

Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects are rare, those considering these drugs for weight loss should weigh the benefits against potential risks, especially if not using them for diabetes.

Cedars-Sinai researchers discover why some injured kidneys heal while others develop scarring

Cedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kidney failure.

February 23, 2024

HealthTap and NaphCare Partner to Bring Virtual Care to Correctional Facilities

What You Should Know: – HealthTap, a leading virtual healthcare provider delivering affordable, high-quality primary care, today announced a nationwide collaboration with leading correctional health care

February 13, 2025

FDA Panel Backs Cryoablation in Early Breast Cancer as Alternative to Surgery

An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients. By a 9-5 vote, the

November 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.